Key facts
- This page summarizes Gino Santini's Form 4 filing for COLLEGIUM PHARMACEUTICAL, INC (COLL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 10 Jun 2026, 16:10.
Gino Santini - 08 Jun 2026 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)
- Reporting relationship
- Director
- Issuer ticker
- COLL
- Reported as of
- 08 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Jun 2026, 16:10:05 UTC
- Prior SEC filing
- 29 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Colleen Tupper as Attorney-in-Fact for Gino Santini
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Gino Santini filed Form 4 for COLLEGIUM PHARMACEUTICAL, INC (COLL) on 10 Jun 2026.
Change
- Previous filing in this sequence was filed on 29 May 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001276038
Primary reporting owner
SANTINI GINO
- Relationship
- Director
- Address
- C/O COLLEGIUM PHARMACEUTICAL, INC., 100 TECHNOLOGY CENTER DRIVE, STOUGHTON
- Signature
- /s/ Colleen Tupper as Attorney-in-Fact for Gino Santini
- Signature date
- 10 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
COLL
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +8,700
- Change %
- +8.4%
- Price
- $16.49*
- Shares after
- 112,483
- Date
- 08 Jun 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
COLL
transaction
Derivative
Stock Option (Right to Purchase)
Options Exercise
- Transaction value
- Shares
- -8,700
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 08 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,700
- Exercise price
- $16.49
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The option is fully vested and exercisable.